Skip to content

Elevance Health

NYSE: ELV · USD

Elevance Health financials

6 charts

Revenue

USD millions

$50,474M
Elevance Health Revenue. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
PeriodRevenue
FY 2009 Q2$15,413.2M; Change unavailable vs FY 2009 Q1
FY 2009 Q3$15,425.1M; +0.1% vs FY 2009 Q2
FY 2009 Q4$19,046.5M; +23.5% vs FY 2009 Q3
FY 2010 Q1$15,098.5M; −20.7% vs FY 2009 Q4
FY 2010 Q2$14,457.2M; −4.2% vs FY 2010 Q1
FY 2010 Q3$14,598.2M; +1.0% vs FY 2010 Q2
FY 2010 Q4$14,647.9M; +0.3% vs FY 2010 Q3
FY 2011 Q1$14,894.3M; +1.7% vs FY 2010 Q4
FY 2011 Q2$15,100.7M; +1.4% vs FY 2011 Q1
FY 2011 Q3$15,398M; +2.0% vs FY 2011 Q2
FY 2011 Q4$15,317.7M; −0.5% vs FY 2011 Q3
FY 2012 Q1$15,415.2M; +0.6% vs FY 2011 Q4
FY 2012 Q2$15,407.3M; −0.1% vs FY 2012 Q1
FY 2012 Q3$15,353.1M; −0.4% vs FY 2012 Q2
FY 2012 Q4$15,536.1M; +1.2% vs FY 2012 Q3
FY 2013 Q1$17,687.2M; +13.8% vs FY 2012 Q4
FY 2013 Q2$17,795.6M; +0.6% vs FY 2013 Q1
FY 2013 Q3$17,969.8M; +1.0% vs FY 2013 Q2
FY 2013 Q4$17,901.7M; −0.4% vs FY 2013 Q3
FY 2014 Q1$17,859.4M; −0.2% vs FY 2013 Q4
FY 2014 Q2$18,473.4M; +3.4% vs FY 2014 Q1
FY 2014 Q3$18,557M; +0.5% vs FY 2014 Q2
FY 2014 Q4$18,984.3M; +2.3% vs FY 2014 Q3
FY 2015 Q1$19,051.5M; +0.4% vs FY 2014 Q4
FY 2015 Q2$20,015.5M; +5.1% vs FY 2015 Q1
FY 2015 Q3$19,901.6M; −0.6% vs FY 2015 Q2
FY 2015 Q4$20,187.9M; +1.4% vs FY 2015 Q3
FY 2016 Q1$20,288.5M; +0.5% vs FY 2015 Q4
FY 2016 Q2$21,456.2M; +5.8% vs FY 2016 Q1
FY 2016 Q3$21,403.9M; −0.2% vs FY 2016 Q2
FY 2016 Q4$21,714.4M; +1.5% vs FY 2016 Q3
FY 2017 Q1$22,525.9M; +3.7% vs FY 2016 Q4
FY 2017 Q2$22,407.2M; −0.5% vs FY 2017 Q1
FY 2017 Q3$22,426M; +0.1% vs FY 2017 Q2
FY 2017 Q4$22,680.3M; +1.1% vs FY 2017 Q3
FY 2018 Q1$22,537.5M; −0.6% vs FY 2017 Q4
FY 2018 Q2$22,943.7M; +1.8% vs FY 2018 Q1
FY 2018 Q3$23,251M; +1.3% vs FY 2018 Q2
FY 2018 Q4$23,373M; +0.5% vs FY 2018 Q3
FY 2019 Q1$24,666M; +5.5% vs FY 2018 Q4
FY 2019 Q2$25,466M; +3.2% vs FY 2019 Q1
FY 2019 Q3$26,674M; +4.7% vs FY 2019 Q2
FY 2019 Q4$27,407M; +2.7% vs FY 2019 Q3
FY 2020 Q1$29,621M; +8.1% vs FY 2019 Q4
FY 2020 Q2$29,264M; −1.2% vs FY 2020 Q1
FY 2020 Q3$31,158M; +6.5% vs FY 2020 Q2
FY 2020 Q4$31,824M; +2.1% vs FY 2020 Q3
FY 2021 Q1$32,385M; +1.8% vs FY 2020 Q4
FY 2021 Q2$33,851M; +4.5% vs FY 2021 Q1
FY 2021 Q3$35,822M; +5.8% vs FY 2021 Q2
FY 2021 Q4$36,581M; +2.1% vs FY 2021 Q3
FY 2022 Q1$38,095M; +4.1% vs FY 2021 Q4
FY 2022 Q2$38,632M; +1.4% vs FY 2022 Q1
FY 2022 Q3$39,939M; +3.4% vs FY 2022 Q2
FY 2022 Q4$39,929M; 0.0% vs FY 2022 Q3
FY 2023 Q1$42,172M; +5.6% vs FY 2022 Q4
FY 2023 Q2$43,672M; +3.6% vs FY 2023 Q1
FY 2023 Q3$42,849M; −1.9% vs FY 2023 Q2
FY 2023 Q4$42,647M; −0.5% vs FY 2023 Q3
FY 2024 Q1$42,577M; −0.2% vs FY 2023 Q4
FY 2024 Q2$43,886M; +3.1% vs FY 2024 Q1
FY 2024 Q3$45,106M; +2.8% vs FY 2024 Q2
FY 2024 Q4$45,442M; +0.7% vs FY 2024 Q3
FY 2025 Q1$48,891M; +7.6% vs FY 2024 Q4
FY 2025 Q2$49,776M; +1.8% vs FY 2025 Q1
FY 2025 Q3$50,711M; +1.9% vs FY 2025 Q2
FY 2025 Q4$49,747M; −1.9% vs FY 2025 Q3
FY 2026 Q1$50,181M; +0.9% vs FY 2025 Q4
FY 2026 Q2$50,474M; +0.6% vs FY 2026 Q1
Jun 30, 2009 through Sep 25, 2026

Net income

USD millions

$1,463M
Elevance Health Net income. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
PeriodNet income
FY 2009 Q2$693.5M; Change unavailable vs FY 2009 Q1
FY 2009 Q3$730.2M; +5.3% vs FY 2009 Q2
FY 2009 Q4$2,741.8M; +275.5% vs FY 2009 Q3
FY 2010 Q1$876.8M; −68.0% vs FY 2009 Q4
FY 2010 Q2$722.4M; −17.6% vs FY 2010 Q1
FY 2010 Q3$739.1M; +2.3% vs FY 2010 Q2
FY 2010 Q4$548.8M; −25.7% vs FY 2010 Q3
FY 2011 Q1$926.6M; +68.8% vs FY 2010 Q4
FY 2011 Q2$701.6M; −24.3% vs FY 2011 Q1
FY 2011 Q3$683.2M; −2.6% vs FY 2011 Q2
FY 2011 Q4$335.3M; −50.9% vs FY 2011 Q3
FY 2012 Q1$856.5M; +155.4% vs FY 2011 Q4
FY 2012 Q2$643.6M; −24.9% vs FY 2012 Q1
FY 2012 Q3$691.2M; +7.4% vs FY 2012 Q2
FY 2012 Q4$464.2M; −32.8% vs FY 2012 Q3
FY 2013 Q1$885.2M; +90.7% vs FY 2012 Q4
FY 2013 Q2$800.1M; −9.6% vs FY 2013 Q1
FY 2013 Q3$656.2M; −18.0% vs FY 2013 Q2
FY 2013 Q4$148.2M; −77.4% vs FY 2013 Q3
FY 2014 Q1$701M; +373.0% vs FY 2013 Q4
FY 2014 Q2$731.1M; +4.3% vs FY 2014 Q1
FY 2014 Q3$630.9M; −13.7% vs FY 2014 Q2
FY 2014 Q4$506.7M; −19.7% vs FY 2014 Q3
FY 2015 Q1$865.2M; +70.8% vs FY 2014 Q4
FY 2015 Q2$859.1M; −0.7% vs FY 2015 Q1
FY 2015 Q3$654.8M; −23.8% vs FY 2015 Q2
FY 2015 Q4$180.9M; −72.4% vs FY 2015 Q3
FY 2016 Q1$703M; +288.6% vs FY 2015 Q4
FY 2016 Q2$780.6M; +11.0% vs FY 2016 Q1
FY 2016 Q3$617.8M; −20.9% vs FY 2016 Q2
FY 2016 Q4$368.4M; −40.4% vs FY 2016 Q3
FY 2017 Q1$1,009.9M; +174.1% vs FY 2016 Q4
FY 2017 Q2$855.3M; −15.3% vs FY 2017 Q1
FY 2017 Q3$746.9M; −12.7% vs FY 2017 Q2
FY 2017 Q4$1,230.7M; +64.8% vs FY 2017 Q3
FY 2018 Q1$1,312.5M; +6.6% vs FY 2017 Q4
FY 2018 Q2$1,053.4M; −19.7% vs FY 2018 Q1
FY 2018 Q3$960M; −8.9% vs FY 2018 Q2
FY 2018 Q4$424M; −55.8% vs FY 2018 Q3
FY 2019 Q1$1,551M; +265.8% vs FY 2018 Q4
FY 2019 Q2$1,139M; −26.6% vs FY 2019 Q1
FY 2019 Q3$1,183M; +3.9% vs FY 2019 Q2
FY 2019 Q4$934M; −21.0% vs FY 2019 Q3
FY 2020 Q1$1,523M; +63.1% vs FY 2019 Q4
FY 2020 Q2$2,276M; +49.4% vs FY 2020 Q1
FY 2020 Q3$222M; −90.2% vs FY 2020 Q2
FY 2020 Q4$551M; +148.2% vs FY 2020 Q3
FY 2021 Q1$1,665M; +202.2% vs FY 2020 Q4
FY 2021 Q2$1,793M; +7.7% vs FY 2021 Q1
FY 2021 Q3$1,509M; −15.8% vs FY 2021 Q2
FY 2021 Q4$1,137M; −24.7% vs FY 2021 Q3
FY 2022 Q1$1,805M; +58.8% vs FY 2021 Q4
FY 2022 Q2$1,653M; −8.4% vs FY 2022 Q1
FY 2022 Q3$1,618M; −2.1% vs FY 2022 Q2
FY 2022 Q4$949M; −41.3% vs FY 2022 Q3
FY 2023 Q1$1,989M; +109.6% vs FY 2022 Q4
FY 2023 Q2$1,853M; −6.8% vs FY 2023 Q1
FY 2023 Q3$1,289M; −30.4% vs FY 2023 Q2
FY 2023 Q4$856M; −33.6% vs FY 2023 Q3
FY 2024 Q1$2,246M; +162.4% vs FY 2023 Q4
FY 2024 Q2$2,300M; +2.4% vs FY 2024 Q1
FY 2024 Q3$1,016M; −55.8% vs FY 2024 Q2
FY 2024 Q4$418M; −58.9% vs FY 2024 Q3
FY 2025 Q1$2,183M; +422.2% vs FY 2024 Q4
FY 2025 Q2$1,743M; −20.2% vs FY 2025 Q1
FY 2025 Q3$1,189M; −31.8% vs FY 2025 Q2
FY 2025 Q4$547M; −54.0% vs FY 2025 Q3
FY 2026 Q1$1,764M; +222.5% vs FY 2025 Q4
FY 2026 Q2$1,463M; −17.1% vs FY 2026 Q1

Net margin

%

2.9%
Elevance Health Net margin. Reported fiscal history.
Fiscal period%
FY 2009 Q24.5%
FY 2009 Q34.73%
FY 2009 Q414.4%
FY 2010 Q15.81%
FY 2010 Q25%
FY 2010 Q35.06%
FY 2010 Q43.75%
FY 2011 Q16.22%
FY 2011 Q24.65%
FY 2011 Q34.44%
FY 2011 Q42.19%
FY 2012 Q15.56%
FY 2012 Q24.18%
FY 2012 Q34.5%
FY 2012 Q42.99%
FY 2013 Q15%
FY 2013 Q24.5%
FY 2013 Q33.65%
FY 2013 Q40.83%
FY 2014 Q13.93%
FY 2014 Q23.96%
FY 2014 Q33.4%
FY 2014 Q42.67%
FY 2015 Q14.54%
FY 2015 Q24.29%
FY 2015 Q33.29%
FY 2015 Q40.9%
FY 2016 Q13.47%
FY 2016 Q23.64%
FY 2016 Q32.89%
FY 2016 Q41.7%
FY 2017 Q14.48%
FY 2017 Q23.82%
FY 2017 Q33.33%
FY 2017 Q45.43%
FY 2018 Q15.82%
FY 2018 Q24.59%
FY 2018 Q34.13%
FY 2018 Q41.81%
FY 2019 Q16.29%
FY 2019 Q24.47%
FY 2019 Q34.44%
FY 2019 Q43.41%
FY 2020 Q15.14%
FY 2020 Q27.78%
FY 2020 Q30.71%
FY 2020 Q41.73%
FY 2021 Q15.14%
FY 2021 Q25.3%
FY 2021 Q34.21%
FY 2021 Q43.11%
FY 2022 Q14.74%
FY 2022 Q24.28%
FY 2022 Q34.05%
FY 2022 Q42.38%
FY 2023 Q14.72%
FY 2023 Q24.24%
FY 2023 Q33.01%
FY 2023 Q42.01%
FY 2024 Q15.28%
FY 2024 Q25.24%
FY 2024 Q32.25%
FY 2024 Q40.92%
FY 2025 Q14.47%
FY 2025 Q23.5%
FY 2025 Q32.34%
FY 2025 Q41.1%
FY 2026 Q13.52%
FY 2026 Q22.9%

P/E

× · TTM · Daily

17.39×
Elevance Health P/E. Monthly closing observations; inspect daily values with the chart arrow keys.
Close date× · TTM · DailyFinancials through
2011-02-289.57×2010-12-31
2011-03-3110.05×2010-12-31
2011-04-299.92×2011-03-31
2011-05-3110.1×2011-03-31
2011-06-3010.17×2011-03-31
2011-07-298.61×2011-06-30
2011-08-318.06×2011-06-30
2011-09-308.32×2011-06-30
2011-10-318.68×2011-09-30
2011-11-308.89×2011-09-30
2011-12-308.35×2011-09-30
2012-01-318.1×2011-09-30
2012-02-298.67×2011-12-31
2012-03-309.75×2011-12-31
2012-04-308.92×2012-03-31
2012-05-318.87×2012-03-31
2012-06-298.39×2012-03-31
2012-07-317.01×2012-06-30
2012-08-317.87×2012-06-30
2012-09-287.63×2012-06-30
2012-10-318.06×2012-06-30
2012-11-307.12×2012-09-30
2012-12-317.76×2012-09-30
2013-01-318.26×2012-09-30
2013-02-287.92×2012-09-30
2013-03-288.44×2012-09-30
2013-04-308.31×2013-03-31
2013-05-318.77×2013-03-31
2013-06-289.33×2013-03-31
2013-07-319.75×2013-03-31
2013-08-309.7×2013-03-31
2013-09-309.53×2013-03-31
2013-10-319.66×2013-03-31
2013-11-2910.58×2013-03-31
2013-12-3110.53×2013-03-31
2014-01-319.8×2013-03-31
2014-02-2810.98×2013-12-31
2014-03-3112.06×2013-12-31
2014-04-3012.2×2013-12-31
2014-05-3013.13×2013-12-31
2014-06-3013.04×2013-12-31
2014-07-3114.04×2014-06-30
2014-08-2914.9×2014-06-30
2014-09-3015.3×2014-06-30
2014-10-3116.28×2014-09-30
2014-11-2816.43×2014-09-30
2014-12-3116.15×2014-09-30
2015-01-3017.34×2014-09-30
2015-02-2716.02×2014-12-31
2015-03-3116.89×2014-12-31
2015-04-3015.48×2015-03-31
2015-05-2917.22×2015-03-31
2015-06-3016.83×2015-03-31
2015-07-3114.79×2015-06-30
2015-08-3113.52×2015-06-30
2015-09-3013.42×2015-06-30
2015-10-3012.98×2015-09-30
2015-11-3012.16×2015-09-30
2015-12-3113.01×2015-09-30
2016-01-2912.17×2015-09-30
2016-02-2913.67×2015-12-31
2016-03-3114.54×2015-12-31
2016-04-2915.7×2016-03-31
2016-05-3114.74×2016-03-31
2016-06-3014.65×2016-03-31
2016-07-2915.19×2016-06-30
2016-08-3114.46×2016-06-30
2016-09-3014.49×2016-06-30
2016-10-3114.09×2016-06-30
2016-11-3016.74×2016-09-30
2016-12-3016.89×2016-09-30
2017-01-3118.11×2016-09-30
2017-02-2817.93×2016-12-31
2017-03-3117.99×2016-12-31
2017-04-2817.32×2017-03-31
2017-05-3117.76×2017-03-31
2017-06-3018.32×2017-03-31
2017-07-3117.68×2017-06-30
2017-08-3118.62×2017-06-30
2017-09-2918.03×2017-06-30
2017-10-3118.74×2017-09-30
2017-11-3021.05×2017-09-30
2017-12-2920.16×2017-09-30
2018-01-3122.2×2017-09-30
2018-02-2816.11×2017-12-31
2018-03-2915.04×2017-12-31
2018-04-3014.96×2018-03-31
2018-05-3114.04×2018-03-31
2018-06-2915.09×2018-03-31
2018-07-3115.41×2018-06-30
2018-08-3116.12×2018-06-30
2018-09-2816.69×2018-06-30
2018-10-3116.78×2018-06-30
2018-11-3016.9×2018-09-30
2018-12-3115.3×2018-09-30
2019-01-3117.65×2018-09-30
2019-02-2817.52×2018-09-30
2019-03-2916.72×2018-09-30
2019-04-3015.32×2018-09-30
2019-05-3116.19×2018-09-30
2019-06-2816.44×2018-09-30
2019-07-3117.16×2018-09-30
2019-08-3015.23×2018-09-30
2019-09-3013.98×2018-09-30
2019-10-3115.67×2018-09-30
2019-11-2916.81×2018-09-30
2019-12-3117.59×2018-09-30
2020-01-3115.45×2018-09-30
2020-02-2814.97×2018-09-30
2020-03-3113.22×2018-09-30
2020-04-3016.35×2018-09-30
2020-05-2917.13×2018-09-30
2020-06-3015.32×2018-09-30
2020-07-3115.95×2018-09-30
2020-08-3116.4×2018-09-30
2020-09-3015.64×2018-09-30
2020-10-3015.89×2018-09-30
2020-11-3018.14×2018-09-30
2020-12-3118.7×2018-09-30
2021-01-2917.3×2018-09-30
2021-02-2618.35×2019-09-30
2021-03-3121.72×2019-09-30
2021-04-3019.98×2021-03-31
2021-05-2820.97×2021-03-31
2021-06-3020.1×2021-03-31
2021-07-3022.45×2021-06-30
2021-08-3121.94×2021-06-30
2021-09-3021.8×2021-06-30
2021-10-2919.4×2021-09-30
2021-11-3018.11×2021-09-30
2021-12-3120.67×2021-09-30
2022-01-3119.66×2021-09-30
2022-02-2820.14×2021-09-30
2022-03-3121.9×2021-09-30
2022-04-2919.65×2022-03-31
2022-05-3119.95×2022-03-31
2022-06-3018.89×2022-03-31
2022-07-2919.02×2022-06-30
2022-08-3119.34×2022-06-30
2022-09-3018.11×2022-06-30
2022-10-3121.31×2022-09-30
2022-11-3020.77×2022-09-30
2022-12-3020×2022-09-30
2023-01-3119.49×2022-09-30
2023-02-2818.81×2022-12-31
2023-03-3118.42×2022-12-31
2023-04-2818.09×2023-03-31
2023-05-3117.29×2023-03-31
2023-06-3017.15×2023-03-31
2023-07-3118.21×2023-03-31
2023-08-3117.06×2023-03-31
2023-09-2916.81×2023-03-31
2023-10-3117.38×2023-03-31
2023-11-3018.51×2023-03-31
2023-12-2918.2×2023-03-31
2024-01-3119.05×2023-03-31
2024-02-2919.35×2023-03-31
2024-03-2820.02×2023-03-31
2024-04-3020.41×2023-03-31
2024-05-3120.79×2023-03-31
2024-06-2820.92×2023-03-31
2024-07-3119.74×2023-06-30
2024-08-3020.66×2023-06-30
2024-09-3019.29×2023-06-30
2024-10-3115.78×2023-09-30
2024-11-2915.83×2023-09-30
2024-12-3114.35×2023-09-30
2025-01-3115.39×2023-09-30
2025-02-2815.44×2023-09-30
2025-03-3116.92×2023-09-30
2025-04-3016.36×2023-09-30
2025-05-3014.93×2023-09-30
2025-06-3015.13×2023-09-30
2025-07-3111.01×2023-09-30
2025-08-2912.39×2023-09-30
2025-09-3012.57×2023-09-30
2025-10-3112.34×2023-09-30
2025-11-2813.16×2023-09-30
2025-12-3113.64×2023-09-30
2026-01-3013.45×2023-09-30
2026-02-2712.53×2025-12-31
2026-03-3111.46×2025-12-31
2026-04-3015.82×2026-03-31
2026-05-2916.53×2026-03-31
2026-06-3016.26×2026-03-31
2026-07-3116.5×2026-06-30
2026-08-3117.23×2026-06-30
2026-09-2517.39×2026-06-30
Mean 15.29×Median 15.99×9% above median

ROE

% · Annual / TTM

11.2%
Elevance Health ROE. Reported fiscal history.
Fiscal period% · Annual / TTM
FY 2009 Q2—
FY 2009 Q3—
FY 2009 Q4—
FY 2010 Q1—
FY 2010 Q222.03%
FY 2010 Q321.51%
FY 2010 Q411.86%
FY 2011 Q112.11%
FY 2011 Q212.16%
FY 2011 Q311.9%
FY 2011 Q411.24%
FY 2012 Q110.85%
FY 2012 Q210.53%
FY 2012 Q310.63%
FY 2012 Q411.28%
FY 2013 Q111.22%
FY 2013 Q211.79%
FY 2013 Q311.54%
FY 2013 Q410.25%
FY 2014 Q19.48%
FY 2014 Q29.15%
FY 2014 Q39.01%
FY 2014 Q410.49%
FY 2015 Q111.23%
FY 2015 Q212.07%
FY 2015 Q312.14%
FY 2015 Q410.83%
FY 2016 Q110.02%
FY 2016 Q29.81%
FY 2016 Q39.51%
FY 2016 Q410.26%
FY 2017 Q111.19%
FY 2017 Q211.26%
FY 2017 Q311.76%
FY 2017 Q414.89%
FY 2018 Q115.61%
FY 2018 Q215.75%
FY 2018 Q316.56%
FY 2018 Q413.63%
FY 2019 Q113.99%
FY 2019 Q213.69%
FY 2019 Q314.22%
FY 2019 Q415.95%
FY 2020 Q115.49%
FY 2020 Q218.13%
FY 2020 Q315.19%
FY 2020 Q414.08%
FY 2021 Q114.38%
FY 2021 Q212.19%
FY 2021 Q315.84%
FY 2021 Q417.63%
FY 2022 Q117.88%
FY 2022 Q217.25%
FY 2022 Q317.32%
FY 2022 Q416.65%
FY 2023 Q116.93%
FY 2023 Q217.32%
FY 2023 Q316.34%
FY 2023 Q415.84%
FY 2024 Q116.02%
FY 2024 Q216.65%
FY 2024 Q315.62%
FY 2024 Q414.83%
FY 2025 Q114.24%
FY 2025 Q212.48%
FY 2025 Q312.61%
FY 2025 Q413.29%
FY 2026 Q112.14%
FY 2026 Q211.2%

Capital allocation

% of tracked cash uses

$894M
Elevance Health capital allocation. Quarterly values. Missing values are unavailable.
PeriodCapexAcquisitionsBuybacksDividendsDebt repaymentsTracked uses
FY 2009 Q211.77% · $89M8.62% · $65.2M57.78% · $437MUnavailable21.83% · $165.1M100% · $756.3M
FY 2009 Q311.25% · $114.4M0% · $0M68.14% · $693.2MUnavailable20.61% · $209.7M100% · $1,017.3M
FY 2009 Q48.49% · $106.1M0% · $0M66.19% · $827MUnavailable25.32% · $316.4M100% · $1,249.5M
FY 2010 Q17.89% · $120.2M0.02% · $0.3M91.1% · $1,388.4MUnavailable0.99% · $15.1M100% · $1,524M
FY 2010 Q26.21% · $102.6M0% · $0M90.36% · $1,493MUnavailable3.43% · $56.7M100% · $1,652.3M
FY 2010 Q311.28% · $110.8MUnavailable47.19% · $463.7MUnavailable41.54% · $408.2M100% · $982.7M
FY 2010 Q410.38% · $117.8MUnavailable89.47% · $1,015.2MUnavailable0.15% · $1.7M100% · $1,134.7M
FY 2011 Q16.22% · $101.9M0% · $0M45.3% · $741.6M5.67% · $92.8M42.81% · $700.8M100% · $1,637.1M
FY 2011 Q211.48% · $104.7M0% · $0M78.33% · $714.7M9.98% · $91.1M0.21% · $1.9M100% · $912.4M
FY 2011 Q37.44% · $127.8M35.07% · $602.3M52.29% · $897.9M5.14% · $88.2M0.06% · $1.1M100% · $1,717.3M
FY 2011 Q419.33% · $185.1MUnavailable71.59% · $685.6M8.95% · $85.7M0.14% · $1.3M100% · $957.7M
FY 2012 Q19.89% · $123.8M0.1% · $1.2M54.32% · $679.8M7.66% · $95.8M28.03% · $350.8M100% · $1,251.4M
FY 2012 Q26.03% · $102.2M53.37% · $904.1M29.15% · $493.8M5.52% · $93.5M5.92% · $100.3M100% · $1,693.9M
FY 2012 Q38.37% · $149.1M4.88% · $87M36.77% · $655.2M5.09% · $90.7M44.9% · $800.1M100% · $1,782.1M
FY 2012 Q43.75% · $169.8M79.58% · $3,604.7M14.75% · $668M1.92% · $87.1M0% · $0.1M100% · $4,529.7M
FY 2013 Q19.62% · $107.5M0% · $0M30.43% · $340.2M10.14% · $113.4M49.81% · $556.9M100% · $1,118M
FY 2013 Q226.79% · $142MUnavailable51.94% · $275.3M21.26% · $112.7M0% · $0M100% · $530M
FY 2013 Q37.66% · $158.6MUnavailable26.81% · $554.9M5.38% · $111.4M60.15% · $1,245M100% · $2,069.9M
FY 2013 Q429.85% · $238.4M0% · $0M56.31% · $449.7M13.84% · $110.5M0% · $0M100% · $798.6M
FY 2014 Q18.78% · $135.7M0% · $0M81.68% · $1,262.8M7.98% · $123.4M1.57% · $24.2M100% · $1,546.1M
FY 2014 Q212.42% · $135.5M0% · $0M74.63% · $814.4M11.04% · $120.5M1.92% · $20.9M100% · $1,091.3M
FY 2014 Q35.53% · $139.4M0% · $0M22.93% · $578.6M4.72% · $119.2M66.82% · $1,685.7M100% · $2,522.9M
FY 2014 Q439.76% · $304M0% · $0M44.86% · $343M15.38% · $117.6MUnavailable100% · $764.6M
FY 2015 Q15.28% · $88.8M37.81% · $635.8M46.03% · $774.1M9.91% · $166.6M0.98% · $16.4M100% · $1,681.7M
FY 2015 Q24.93% · $140.9M0.2% · $5.8M22.25% · $636.5M5.73% · $163.9M66.89% · $1,913.6M100% · $2,860.7M
FY 2015 Q319.77% · $178.6MUnavailable11.65% · $105.2M18.04% · $163M50.54% · $456.5M100% · $903.3M
FY 2015 Q432.55% · $229.9M0.38% · $2.7M0% · $0M23.09% · $163.1M43.98% · $310.7M100% · $706.4M
FY 2016 Q140.77% · $117.5M0% · $0M0% · $0M59.23% · $170.7M0% · $0M100% · $288.2M
FY 2016 Q243.89% · $133.7M0% · $0M0% · $0M56.11% · $170.9M0% · $0M100% · $304.6M
FY 2016 Q349% · $164.4M0% · $0M0% · $0M51% · $171.1M0% · $0M100% · $335.5M
FY 2016 Q449.51% · $168M0% · $0M0% · $0M50.49% · $171.3M0% · $0M100% · $339.3M
FY 2017 Q117.01% · $127.9M0% · $0M6.74% · $50.7M22.9% · $172.2M53.34% · $401.1M100% · $751.9M
FY 2017 Q212.77% · $169.6M0% · $0M34.5% · $458.3M12.93% · $171.8M39.8% · $528.8M100% · $1,328.5M
FY 2017 Q314.02% · $218.7M2.17% · $33.9M72.19% · $1,126.4M11.63% · $181.4M0% · $0M100% · $1,560.4M
FY 2017 Q45.96% · $283.3M43.01% · $2,045.7M7.62% · $362.3M3.77% · $179.5M39.64% · $1,885.2M100% · $4,756M
FY 2018 Q17.76% · $218.2M47.84% · $1,346.1M14.03% · $394.7M6.82% · $191.9M23.55% · $662.7M100% · $2,813.6M
FY 2018 Q224.41% · $314.3M29.23% · $376.4M31.09% · $400.3M15.25% · $196.4M0.02% · $0.3M100% · $1,287.7M
FY 2018 Q321.07% · $355.5M0.56% · $9.5M23.53% · $397M11.56% · $195M43.27% · $730M100% · $1,687M
FY 2018 Q424.15% · $320M2.11% · $28M37.21% · $493M14.57% · $193M21.96% · $291M100% · $1,325M
FY 2019 Q129.36% · $234M0% · $0M36.89% · $294M25.85% · $206M7.9% · $63M100% · $797M
FY 2019 Q224.69% · $221M0% · $0M51.17% · $458M23.02% · $206M1.12% · $10M100% · $895M
FY 2019 Q313.76% · $271M0% · $0M32.71% · $644M10.36% · $204M43.17% · $850M100% · $1,969M
FY 2019 Q433.18% · $351M0% · $0M28.83% · $305M19.09% · $202M18.9% · $200M100% · $1,058M
FY 2020 Q16.96% · $204M65.05% · $1,908M18.04% · $529M8.18% · $240M1.77% · $52M100% · $2,933M
FY 2020 Q236.81% · $233MUnavailable8.69% · $55M38.23% · $242M16.27% · $103M100% · $633M
FY 2020 Q314.05% · $306M3.08% · $67M34.8% · $758M10.93% · $238M37.14% · $809M100% · $2,178M
FY 2020 Q49.79% · $278M0.11% · $3M47.8% · $1,358M8.24% · $234M34.07% · $968M100% · $2,841M
FY 2021 Q121.36% · $204M2.83% · $27M46.81% · $447M29.01% · $277M0% · $0M100% · $955M
FY 2021 Q25.27% · $285M63.12% · $3,415M8.87% · $480M5.14% · $278M17.6% · $952M100% · $5,410M
FY 2021 Q326.14% · $258M0% · $0M45.69% · $451M27.96% · $276M0.2% · $2M100% · $987M
FY 2021 Q426.5% · $340M2.65% · $34M40.69% · $522M21.28% · $273M8.89% · $114M100% · $1,283M
FY 2022 Q121.47% · $254M5.16% · $61M46.07% · $545M26.12% · $309M1.18% · $14M100% · $1,183M
FY 2022 Q210.91% · $295M20.26% · $548M23.07% · $624M11.42% · $309M34.34% · $929M100% · $2,705M
FY 2022 Q324.54% · $305M1.13% · $14M46.58% · $579M24.62% · $306M3.14% · $39M100% · $1,243M
FY 2022 Q414.1% · $298M1.23% · $26M26.87% · $568M14.43% · $305M43.38% · $917M100% · $2,114M
FY 2023 Q16.24% · $301M33.98% · $1,638M12.9% · $622M7.28% · $351M39.59% · $1,908M100% · $4,820M
FY 2023 Q225.75% · $350M0.96% · $13M47.53% · $646M25.75% · $350M0% · $0M100% · $1,359M
FY 2023 Q327.81% · $319MUnavailable41.85% · $480M30.34% · $348M0% · $0M100% · $1,147M
FY 2023 Q420.36% · $326MUnavailable57.96% · $928M21.61% · $346M0.06% · $1M100% · $1,601M
FY 2024 Q111.9% · $279M47.78% · $1,120M24.15% · $566M16.17% · $379M0% · $0M100% · $2,344M
FY 2024 Q227.65% · $323M0.34% · $4M39.64% · $463M32.36% · $378M0% · $0M100% · $1,168M
FY 2024 Q321.15% · $332M0% · $0M3.82% · $60M24.08% · $378M50.96% · $800M100% · $1,570M
FY 2024 Q44.57% · $322M52.34% · $3,685M25.72% · $1,811M5.3% · $373M12.07% · $850M100% · $7,041M
FY 2025 Q17.23% · $196MUnavailable32.45% · $880M14.23% · $386M46.09% · $1,250M100% · $2,712M
FY 2025 Q225.92% · $267MUnavailable36.7% · $378M37.38% · $385M0% · $0M100% · $1,030M
FY 2025 Q314.3% · $360MUnavailable34.8% · $876M15.14% · $381M35.76% · $900M100% · $2,517M
FY 2025 Q425.68% · $293MUnavailable41.28% · $471M33.04% · $377MUnavailable100% · $1,141M
FY 2026 Q19.46% · $235MUnavailable45.23% · $1,124M15.13% · $376M30.18% · $750M100% · $2,485M
FY 2026 Q232.1% · $287M0% · $0M26.17% · $234M41.72% · $373M0% · $0M100% · $894M

Tracked cash uses · SBC excluded

Sources and calculations

Company filings · USD · Last checked 2026-10-18. Missing inputs remain unavailable. Your chart selection and layout are saved in this browser for Elevance Health.

All charts share the selected dates. Quarterly/Yearly changes fiscal charts; valuation keeps completed daily closes on a published TTM basis. Later restatements can delay that basis. Historical mean, median and pricing labels use the selected range and do not estimate intrinsic fair value.

Revenue
Reported revenue from company filings.
Net income
Reported company figures.
Net margin
Reported net income / revenue × 100.
P/E
Completed closing price × diluted shares / TTM earnings attributable to common shareholders.
ROE
Earnings attributable to owners / average equity attributable to owners × 100, using period end and one year earlier.
Capital allocation
Reported cash uses as a percentage of tracked uses. Missing categories remain unavailable; SBC is noncash and excluded.
Reported revenue and sources